PCCA launches UniFlow excipient base for improved thyroid hormone compounding
PCCA has announced the release of UniFlow, a new powder excipient base designed for compounding triturations with highly potent, low-dose active pharmaceutical ingredients such as liothyronine sodium (T3) and levothyroxine sodium (T4). Read More »